HIV/AIDS相关淋巴瘤研究进展

摘要/Abstract

摘要：人类免疫缺陷病毒（HIV）/获得性免疫缺陷综合征（AIDS）相关淋巴瘤（ARL）是一组异质性肿瘤，预后较差。近年来阐明的发病机制包括HIV引起的免疫损伤、EB病毒的感染及基因的改变。ARL的病理类型主要有4种，即弥漫大B细胞淋巴瘤、Burkitt淋巴瘤、原发渗出性淋巴瘤和浆母细胞淋巴瘤。形态学特征、免疫标记和遗传学特点的联合应用有助于诊断和鉴别诊断，从而有利于及时治疗和改善预后。

王迪,冯艳玲. HIV/AIDS相关淋巴瘤研究进展[J]. 国际肿瘤学杂志, 2015, 42(6): 475-477.

Wang Di, Feng Yanling. Research progress of HIV/AIDS related lymphoma[J]. Journal of International Oncology, 2015, 42(6): 475-477.

［1］ Yanik EL, Tamburro K, Eron JJ, et al. Recent cancer incidence trends in an observational clinical cohort of HIV infected patients in the US, 2000 to 2011［J］. Infect Agent Cancer, 2013, 8(1): 18. ［2］ Rabkin CS, Engels EA, Landgren O, et al. Circulating cytokine levels, EpsteinBarr viremia, and risk of acquired immunodeficiency syndromerelated nonHodgkin lymphoma［J］. Am J Hematol, 2011, 86(10): 875-878. ［3］ Marks MA, Rabkin CS, Engels EA, et al. Markers of microbial translocation and risk of AIDSrelated lymphoma［J］. AIDS, 2013, 27(3): 469-474. ［4］ Lamers SL, Fogel GB, Huysentruyt LC, et al. HIV-1 nef protein visits Bcells via macrophage nanotubes: a mechanism for AIDSrelated lymphoma pathogenesis?［J］. Curr HIV Res, 2010, 8(8): 638-640. ［5］ Epeldegui M, Vendrame E, MartínezMaza O. HIVassociated immune dysfunction and viral infection: role in the pathogenesis of AIDSrelated lymphoma［J］. Immunol Res, 2010, 48(1-3): 72-83. ［6］ Imbeault M, Ouellet M, Giguère K, et al. Acquisition of hostderived CD40L by HIV1 in vivo and its functional consequencesin the Bcell compartment［J］. J Virol, 2011, 85(5): 2189-2200. ［7］ Canaan A, Haviv I, Urban AE, et al. EBNA1 regulates cellular gene expression by binding cellular promoters［J］. Proc Natl Acad Sci USA, 2009, 106(52): 22421-22426. ［8］ De Falco G, Antonicelli G, Onnis A, et al. Role of EBV in microRNA dysregulation in Burkitt lymphoma［J］. Semin Cancer Biol, 2009, 19(6): 401-406. ［9］ Leucci E, Onnis A, Cocco M, et al. Bcell differentiation in EBVpositive Burkitt lymphoma is impaired at posttranscriptional level by miRNAaltered expression［J］. Int J Cancer, 2010, 126(6): 1316-1326. ［10］ Dlken L, Malterer G, Erhard F, et al. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma herpesviruses by RISC immunoprecipitation assay［J］. Cell Host Microbe, 2010, 7(4): 324-334. ［11］ Ma SD, Hegde S, Young KH, et al. A new model of EpsteinBarr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas［J］. J Virol, 2011, 85(1): 165-177. ［12］ De Roos AJ, MartínezMaza O, Jerome KR, et al. Investigation of epsteinbarr virus as a potential cause of B cell non-Hodgkin lymphoma in a prospective cohort［J］. Cancer Epidemiol Biomarkers Prev, 2013, 22(10): 1747-1755. ［13］ Nayar U, Lu P, Goldstein RL, et al. Targeting the Hsp90associated viral oncoproteome in gammaherpesvirusassociated malignancies［J］. Blood, 2013, 122(16): 28372847. ［14］ Lei X, Zhu Y, Jones T, et al. A Kaposi′s sarcomaassociated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival［J］. J Virol, 2012, 86(21): 11698-11711. ［15］ Huang X, Shen Y, Liu M, et al. Quantitative proteomics reveals that miR155 regulates the PI3K-AKT pathway in diffuse large B cell lymphoma［J］. Am J Pathol, 2012, 181(1): 26-33. ［16］ Sandhu SK, Fassan M, Volinia S, et al. Bcell malignancies in microRNA Eμ miR17~92 transgenic mice［J］. Proc Natl Acad Sci USA, 2013, 110(45): 18208-18213. ［17］ Craig VJ, Tzankov A, Flori M, et al. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B cell lymphoma in vivo［J］. Leukemia, 2012, 26(11): 2421-2424. ［18］ Gloghini A, Dolcetti R, Carbone A. Lymphomas occurring specifi cally in HIV infected patients: from pathogenesis to pathology［J］. Semin Cancer Biol, 2013, 23(6): 457-467. ［19］邵泽涛, 潘云, 李正金, 等. 人免疫缺陷病毒感染/获得性免疫缺陷综合征相关Burkitt淋巴瘤2例［J］. 中华病理学杂志, 2012, 41(6): 408-410. ［20］ Valera A, Balagué O, Colomo L, et al. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas［J］. Am J Surg Pathol, 2010, 34(11): 1686-1694. ［21］官兵, 张新华, 饶秋, 等. 口腔原发性浆母细胞淋巴瘤临床病理观察［J］. 诊断病理学杂志, 2011, 18(3): 209-212. ［22］ Hedstrm G, Thunberg U, Berglund M, et al. Low expression of microRNA-129 5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)［J］. Int J Hematol, 2013, 97(4): 465-471.

[1]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[2]	张洁, 范玲, 李杰, 温华, 苏媛媛, 路宁, 张明鑫.原发性胰腺淋巴瘤1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(5): 316-320.
[3]	张丽丽, 谭茹, 房雪利, 杨宇, 桑铮, 李宝生.乳腺导管原位癌影像学诊断、病理学升级及影像学技术进展[J]. 国际肿瘤学杂志, 2024, 51(3): 166-169.
[4]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[5]	陈郁, 许华, 刘海, 陈士新.基于CT影像学特征的恶性肺纯磨玻璃结节患者病理分型预测模型构建[J]. 国际肿瘤学杂志, 2023, 50(11): 655-660.
[6]	殷运燕, 李慧, 李雨晨, 惠慧, 许景艳.组蛋白去乙酰化酶抑制剂在非霍奇金淋巴瘤中的临床应用[J]. 国际肿瘤学杂志, 2022, 49(8): 499-504.
[7]	王柳雪, 席晓平, 刘静静, 沈国民, 杨海平.二甲双胍在非霍奇金淋巴瘤中的研究进展[J]. 国际肿瘤学杂志, 2022, 49(7): 436-440.
[8]	孙淑琴, 钱秋红, 张友忠.盆腔原发弥漫性大B细胞淋巴瘤1例[J]. 国际肿瘤学杂志, 2022, 49(5): 319-320.
[9]	郭奕维, 刘爱春.EB病毒阳性弥漫大B细胞淋巴瘤的治疗[J]. 国际肿瘤学杂志, 2021, 48(7): 385-388.
[10]	李巧佴, 邹立群.老年弥漫大B细胞淋巴瘤的分层治疗策略[J]. 国际肿瘤学杂志, 2021, 48(5): 317-320.
[11]	乔薇, 宋腾, 陈馨蕊, 王华庆.PI3K信号通路过度激活对非霍奇金淋巴瘤患者预后的影响及其靶向药物疗效[J]. 国际肿瘤学杂志, 2021, 48(2): 121-124.
[12]	陈丽娜, 郭智, 刘玄勇, 陈晓, 张弋慧智, 李旭绵, 韦丽娅, 王月乔, 谢晶.EAC动员方案在淋巴瘤自体造血干细胞移植中的应用研究[J]. 国际肿瘤学杂志, 2021, 48(11): 666-672.
[13]	许蕾, 戴婧, 张倩, 张文丽, 李晋萌, 张红宇.93例成人急性淋巴细胞白血病的临床分析[J]. 国际肿瘤学杂志, 2020, 47(9): 535-541.
[14]	杨蕾, 张传玉, 张在先, 刘欢.非小细胞肺癌影像基因组学[J]. 国际肿瘤学杂志, 2020, 47(9): 555-559.
[15]	赵可, 王华庆.复发/难治外周T细胞淋巴瘤的新药治疗进展[J]. 国际肿瘤学杂志, 2020, 47(6): 321-326.

Research progress of HIV/AIDS related lymphoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价